|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 产后出血的预防和处理指南显示文摘目的:为产后出血(PPH)的预防和临床处理作一综述,为临床医师提供预防和处理产后出血的指南。涉及方面:预防、适当干预、使其影响最小化的方法。结果:建立常规,便于临床医师鉴别可能的高危人群,一旦发生产后过多出血,可指导临床如何迅速处理。证据:遵循加拿大定期健康检查办公室制定的证据等级。评估:由产科专家完善。利弊和成本:评估子宫收缩药和其他积极处理措施的方便性、正确性、有效性和安全性。建议:根据证据的等级,本指南分等级列出了12条建议。确认:按照MeSH词表推荐的postpartum haemorrhage在medline上查询相关文献,在Cochrane图书馆查找相关研究文献,并参考the ALARMcourse Manual。发起人:由产科临床实践委员会制定和综述,并由SOGC(加拿大妇产科协会)委员会批准。 | Nan Schuurmans MD FRCSC, Edmonton AB Catherine MacKinnon MD FRCSC, Brantford ON Carolyn Lane MD CCFP Calgary AB Duncan Etches MD CCFP Vancouver BC 刘铭(译) 段涛(译) | 2007 | 现代妇产科进展2007，16，3： | 152 |
| 2 | Ocular syphilis: resurgence of an old disease in modern Malaysian society显示文摘Dear Editor,Syphilis is a spirochaetal bacterial sexually transmitted disease(STD) caused by Treponema pallidum. Outbreaks of syphilis have been described in Western communities, especially in men who have sex with men(MSM) and people infected with human immunodeficiency virus(HIV)^([1]). Reports of the condition from Asian countries remains limited, this | Mushawiahti Mustapha Zakaria Abdollah Amin Ahem Hazlita Mohd Isa Mae-Lynn Catherine Bastion Norshamsiah Md Din | 2018 | International Journal of Ophthalmology(English edition)2018，11，9： | 4 |
| 3 | 2,3-Diaryl-3H-imidazo[4,5-b]pyridine derivatives as potential anticancer and anti-inflammatory agents显示文摘In this study we examined the suitability of the 3H-imidazo[4,5-b]pyridine ring system in developing novel anticancer and anti-inflammatory agents incorporating a diaryl pharmacophore. Eight 2,3-diaryl-3H-imidazo[4,5-b]pyridine derivatives retrieved from our in-house database were evaluated for their cytotoxic activity against nine cancer cell lines. The results indicated that the compounds showed moderate cytotoxic activity against MCF-7, MDA-MB-468, K562 and SaOS2 cells, with K562 being the most sensitive among the four cancer cell lines. The eight 2,3-diaryl-3H-imidazo[4,5-b]pyridine derivatives were also evaluated for their COX-1 and COX-2 inhibitory activity in vitro. The results showed that compound 3f exhibited 2-fold selectivity with IC_(50) values of 9.2 and 21.8 mmol/L against COX-2 and COX-1, respectively. Molecular docking studies on the most active compound 3f revealed a binding mode similar to that of celecoxib in the active site of the COX-2 enzyme. | Erin Marie Kirwen Tarun Batra Chandrabose Karthikeyan Girdhar Singh Deora Vandana Rathore Chaitanya Mulakayala Naveen Mulakayala Amy Catherine Nusbaum Joel Chen Haneen Amawi Kyle Mc Intosh Sahabjada Neelam Shivnath Deepak Chowarsia Nisha Sharma Md Arshad Piyush Trivedi Amit KTiwari | 2017 | Acta Pharmaceutica Sinica B2017，7，1： | 3 |
| 4 | A Controlled Trial of a Critical Pathway for Treatment of Community-Acquired Pneumonia 显示文摘 | Thomas T Manle MD Catherine Y Lau | 2000 | The Journal of the American Medical Association2000，283，20： | 1 |
| 5 | Surveillance for morbidity and mortality among older adults- united states, 1995 -- 1996显示文摘 | Mayur MD Ping Z Catherine HH | 1999 | Surveillance Summaries1999，48，08： | 1 |
| 6 | Indication for initiation of mechanical circulatory support impacts survival of infants with shunted single-ventricle circulation supported with extracorporeal membrane oxygenation显示文摘 | Catherine K Allan MD Ravi R | 2007 | J Thorac Cardiovasc Surg2007，133，3： | 1 |
| 7 | Treatmentoutcomes in patients with adult thrombotic thrombocy-topenic purpura hemolytic uremic syndrome 显示文摘 | Catherine PM Hayward MD David M | 1994 | ArchIntern Med1994，154，9： | 1 |
| 8 | A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin显示文摘 | Daniel H. Palmer MRCP PhD Deborah D. Stocken PhD Helen Hewitt RGN Catherine E. Markham RGN A. Bassim Hassan PhD Philip J. Johnson FRCP MD John A. C. Buckels FRCS MD Simon R. Bramhall FRCS MD | 2007 | Annals of Surgical Oncology2007，，7： | 1 |
| 9 | Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study显示文摘 | Ajay V. Maker MD Giao Q. Phan MD Peter Attia MD James C. Yang MD Richard M. Sherry MD Suzanne L. Topalian MD Udai S. Kammula MD Richard E. Royal MD Leah R. Haworth RN Catherine Levy RN David Kleiner MD Sharon A. Mavroukakis RN Michael Yellin MD Steven A. | 2005 | Annals of Surgical Oncology2005，，12： | 1 |
| 10 | Advanced MR imaging of the cruciate ligaments 显示文摘 | Catherine C Roberts MD Jeffery D | 2007 | Radiologic Clinics Of North America2007，45，6： | 1 |
| 11 | Results After Conservative Treatment of Serous Borderline Tumors of the Ovary with a Micropapillary Pattern显示文摘 | Isabelle Laurent MD Catherine Uzan MD Sebastien Gouy MD Patricia Pautier MD Pierre Duvillard MD Philippe Morice MD | 2008 | Annals of Surgical Oncology2008，，12： | 1 |
| 12 | Results After Conservative Treatment of Serous Borderline Tumors of the Ovary with a Micropapillary Pattern显示文摘 | Isabelle Laurent MD Catherine Uzan MD Sebastien Gouy MD Patricia Pautier MD Pierre Duvillard MD Philippe Morice MD | 2008 | Annals of Surgical Oncology2008，，12： | 1 |
| 13 | Pulmonary nodules: preliminary experience with three-dimen- sional evaluation 显示文摘 | Marie-Pierre Revel MD Catherine Lefort MD Alvine Bissery MSc | 2004 | Radiology2004，231，： | 1 |
| 14 | Discriminating causes of dyspnea through clinical examination显示文摘 | Dr. Cynthia D. Mulrow MD MSc Catherine R. Lucey MD Lisa E. Farnett PharmD | 1993 | Journal of General Internal Medicine1993，，7： | 1 |
| 15 | A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin显示文摘 | Daniel H. Palmer MRCP PhD Deborah D. Stocken PhD Helen Hewitt RGN Catherine E. Markham RGN A. Bassim Hassan PhD Philip J. Johnson FRCP MD John A. C. Buckels FRCS MD Simon R. Bramhall FRCS MD | 2007 | Annals of Surgical Oncology2007，，7： | 1 |
| 16 | Prevention and management of postpartum hemor- rhage显示文摘 | Nan Schuurmans MD FRCSC Edmonton AB Catherine MacKin non MD | 2000 | J SOGC2000，88，： | 1 |
| 17 | Neoadjuvant Chemoradiation for Localized Adenocarcinoma of the Pancreas显示文摘 | Rebekah R. White MD Herbert I. Hurwitz MD Michael A. Morse MD Catherine Lee MD Mitchell S. Anscher MD Erik K. Paulson MD Marcia R. Gottfried MD John Baillie MB ChB Malcolm S. Branch MD Paul S. Jowell MB ChB Kevin M. McGrath MD Bryan M. Clary MD Theodore | 2001 | Annals of Surgical Oncology2001，，10： | 1 |
| 18 | Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy显示文摘 | Olivier Glehen MD PhD Fran?ois Noel Gilly MD PhD Catherine Arvieux MD PhD Eddy Cotte MD Florent Boutitie Baudouin Mansvelt MD PhD Jean Marc Bereder MD Gérard Lorimier MD Fran?ois Quenet MD Dominique Elias MD PhD | 2010 | Annals of Surgical Oncology2010，，9： | 1 |
| 19 | Investment bankers and IPO pricing: Does prospectus information matter? 显示文摘 | Catherine MD Certo ST Dalton DR | 2005 | Journal of Business Venturing2005，20，： | 1 |
| 20 | Review of the management of sight-threatening diabetic retinopathy during pregnancy显示文摘Diabetes mellitus(DM)is a noncommunicable disease reaching epidemic proportions around the world.It affects younger individuals,including women of childbearing age.Diabetes can cause diabetic retinopathy(DR),which is potentially sight threatening when severe nonproliferative DR(NPDR),proliferative DR(PDR),or sight-threatening diabetic macular oedema(STDME)develops.Pregnancy is an independent risk factor for the progression of DR.Baseline DR at the onset of pregnancy is an important indicator of progression,with up to 10% of women with baseline NPDR progressing to PDR.Progression to sight-threatening DR(STDR)during pregnancy causes distress to the patient and often necessitates ocular treatment,which may have a systemic effect.Management includes prepregnancy counselling and,when possible,conventional treatment prior to pregnancy.During pregnancy,closer follow-up is required for those with a long duration of DM,poor baseline control of blood sugar and blood pressure,and worse DR,as these are risk factors for progression to STDR.Conventional treatment with anti-vascular endothelial growth factor agents for STDME can potentially lead to foetal loss.Treatment with laser photocoagulation may be preferred,and surgery under general anaesthesia should be avoided.This review provides a management plan for STDR from the perspective of practising ophthalmologists.A review of strategies for maintaining the eyesight of diabetic women with STDR with emphasis on prepregnancy counselling and planning,monitoring and safe treatment during pregnancy,and management of complications is presented. | Priscilla Peixi Choo Norshamsiah Md Din Nooraniah Azmi Mae-Lynn Catherine Bastion | 2021 | World Journal of Diabetes2021，12，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员